Girlich, D.; Jousset, A.B.; Emeraud, C.; Rezzoug, I.; Burwell, R.; Singh, P.; Rhodes, P.A.; Naas, T.; Bonnin, R.A.; Dortet, L.
Evaluation of the Reveal® AST (SPECIFIC) for Antimicrobial Susceptibility Testing from Positive Blood Culture Spiked with Carbapenem-Resistant Isolates. Pathogens 2024, 13, 722.
https://doi.org/10.3390/pathogens13090722
AMA Style
Girlich D, Jousset AB, Emeraud C, Rezzoug I, Burwell R, Singh P, Rhodes PA, Naas T, Bonnin RA, Dortet L.
Evaluation of the Reveal® AST (SPECIFIC) for Antimicrobial Susceptibility Testing from Positive Blood Culture Spiked with Carbapenem-Resistant Isolates. Pathogens. 2024; 13(9):722.
https://doi.org/10.3390/pathogens13090722
Chicago/Turabian Style
Girlich, Delphine, Agnès B. Jousset, Cécile Emeraud, Inès Rezzoug, Reece Burwell, Pragya Singh, Paul A. Rhodes, Thierry Naas, Rémy A. Bonnin, and Laurent Dortet.
2024. "Evaluation of the Reveal® AST (SPECIFIC) for Antimicrobial Susceptibility Testing from Positive Blood Culture Spiked with Carbapenem-Resistant Isolates" Pathogens 13, no. 9: 722.
https://doi.org/10.3390/pathogens13090722
APA Style
Girlich, D., Jousset, A. B., Emeraud, C., Rezzoug, I., Burwell, R., Singh, P., Rhodes, P. A., Naas, T., Bonnin, R. A., & Dortet, L.
(2024). Evaluation of the Reveal® AST (SPECIFIC) for Antimicrobial Susceptibility Testing from Positive Blood Culture Spiked with Carbapenem-Resistant Isolates. Pathogens, 13(9), 722.
https://doi.org/10.3390/pathogens13090722
